Publication | Closed Access

Combination Treatment of Human Pancreatic Cancer Xenograft Models with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib and Oncolytic Herpes Simplex Virus HF10

Tumor BiologyPancreatic CancerMedicineReceptor Tyrosine KinaseImmunologyPathologyCombination TreatmentOncologyRadiation OncologyCancer ResearchViral OncologyCancer-associated Virus